DalCor Pharmaceuticals US
Pharmaceuticals company with a recent SEC Form D offering.
Pharmaceuticals company headquartered in Sarasota, FLORIDA. Filed SEC Form D on 20260828 for a $7.0M Regulation D offering.
Biotech
📍 Sarasota, FLORIDA
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is DalCor Pharmaceuticals US going public?
No. DalCor Pharmaceuticals US is private and has not filed to go public. There is no S-1 on file.
What is DalCor Pharmaceuticals US' valuation in 2026?
No confirmed valuation is on record for DalCor Pharmaceuticals US. The roster shows funding and investors where they are public; it does not estimate a mark.
Has DalCor Pharmaceuticals US filed an S-1?
No public S-1 is on file for DalCor Pharmaceuticals US.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Growth
Filed SEC Form D on 20260828 for $7.0M Regulation D offering
Last Round
Form D filing — $6.96M (20260828)
Fundraising Status
Form D filing · $6.96M
privateTotal raised $6.96M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $6.96M | 20260828 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Biotech / Gene Therapy registry data for DalCor Pharmaceuticals US has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.
Talent Signal
Hiring data for DalCor Pharmaceuticals US has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.